MDPI and ACS Style
Kolokotronis, T.; Majchrzak-Stiller, B.; Buchholz, M.; Mense, V.; Strotmann, J.; Peters, I.; Skrzypczyk, L.; Liffers, S.-T.; Menkene, L.M.; Wagner, M.;
et al. Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers 2024, 16, 2726.
https://doi.org/10.3390/cancers16152726
AMA Style
Kolokotronis T, Majchrzak-Stiller B, Buchholz M, Mense V, Strotmann J, Peters I, Skrzypczyk L, Liffers S-T, Menkene LM, Wagner M,
et al. Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers. 2024; 16(15):2726.
https://doi.org/10.3390/cancers16152726
Chicago/Turabian Style
Kolokotronis, Theodoros, Britta Majchrzak-Stiller, Marie Buchholz, Vanessa Mense, Johanna Strotmann, Ilka Peters, Lea Skrzypczyk, Sven-Thorsten Liffers, Louise Massia Menkene, Mathias Wagner,
and et al. 2024. "Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma" Cancers 16, no. 15: 2726.
https://doi.org/10.3390/cancers16152726